Low serum TNF-α levels in subjects at risk for type 1 diabetes

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue 5, 2000, Pages 475-481

  Vitali, Letizia ^a   De Amici, Mara ^a   D'Annunzio, Giuseppe ^a   Martinetti, Miryam ^a   Alibrandi, Amalia ^a   Lorini, Renata ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Risk factor; TNF ; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CHILD; DIABETOGENESIS; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; IMMUNE SYSTEM; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; RISK FACTOR; SCHOOL CHILD;

EID: 0034060098     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2000.13.5.475     Document Type: Article

References (39)

1. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes. N Engl J Med 1994; 331: 1428-1436.
2. Campbell IL, Iscaro A, Harrison LC. INF-γ and tumor necrosis factor-α. Cytotoxicity to murine islets of Langerhans. J Immunol 1988; 141: 2325-2329.
3. Lorini R, Montagna D, Lanfranchi A, Cortona L, Livieri C, Larizza D, d'Annunzio G, Severi F. Alterations of in vitro interleukin 1 and interleukin 2 in diabetic children. Eur J Pediatr 1989; 148: 732-734.
4. Molving J, Pociot F, Baek L, et al. Monocyte function in IDDM patients and healthy individuals. Scand J Immunol 1990; 32: 297-311.
5. Corbett JA, Kwon G, Marino MH, Rodi CP, Sullivan PM, Turk J, McDaniel ML. Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islet. Am J Physiol 1986; 270: C1581-1587.
6. Rothe H, Fehsel K, Kolb H. Tumor necrosis factor alpha production is upregulated in diabetes prone BB rats. Diabetologia 1990; 33: 573-575.
7. Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers JI, Cuartero BG, Karlsen AE, Bjerre U, Lorenzen T. On the pathogenesis of IDDM. Diabetologia 1994; 37 (Suppl 2): S82-S89.
8. Mandrup-Poulsen T, Pociot F, Molvig J, Shapiro L, Nilsson P, Emdal T, Roder M, Kjems LL, Dinarello CA, Nerup J. Monokine antagonism is reduced in patients with IDDM. Diabetes 1994; 43: 1242-1247.
9. Tracey KJ, Vlassara H, Cerami A. Cachectin/tumour necrosis factor. Lancet 1989; i: 1122-1125.
10. Ghiara P, Boraschi D, Nencioni L, Ghezzi P, Tagliabue A. Enhancement of in vivo immune response by tumor necrosis factor. J Immunol 1987; 139: 3676-3679.
11. Eigler A, Sinha B, Hartmann G, Endres S. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today 1987; 18: 487-492.
12. Jacob CO. Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch? Immunol Today 1992; 13: 122-125.
13. Lapchak PH, Guilbert LJ, Rabinovitch A. Tumor necrosis factor production is deficient in diabetes-prone BB rats and can be corrected by complete Freund's adjuvant: a possible immunoregulatory role of tumor necrosis factor in the prevention of diabetes. Clin Immunol Immunopathol 1992; 65: 129-134.
14. Jacob CO, McDevitt HO. Tumour necrosis factor-alpha in murine autoimmune lupus nephritis. Nature 1988; 331: 356-358.
15. Takahashi K, Satoh J, Sagara M, Muto G, Muto Y, Fukuzawa M, Nishimura S, Miyaguchi S, Qiang XL, Kumagai K, et al. Reduced expression of c-FOS in female NOD mouse thymocytes and upregulation with human lymphotoxin. Cell Immunol 1995; 164: 287-294.
16. Takahashi K, Satoh J, Seino H, Zhu XP, Sagara M, Masuda T, Toyota T. Prevention of type 1 diabetes with lymphotoxin in BB rats. Clin Immunol Immunopathol 1993; 69: 318-323.
17. Lorini R, De Amici M, d'Annunzio G, Vitali L, Scaramuzza A. Low serum levels of tumor necrosis factor alpha in insulin-dependent diabetic children. Horm Res 1995; 45: 206-209.
18. Vanelli M, Boselli E, Neri T, Zanelli P, Chiari G, Vittorangeli R, Rasori E, Bilzi I, Savi M. Markers per diabete tipo I in bambini con glicemie occasionali a digiuno > 100 mg/dl. Riv Ital Pediatr (IJP) 1988; 14: 404-407.
19. Lorini R, Gruppo di Lavoro della SIEDP "Depistaggio e Trattamento dello Stato preclinico del diabete mellito tipo 1". I primi 4 anni di screening del prediabete in Italia. Riv Ital Pediatr (IJP) 1996; 22: 591-596.
20. Lorini R, Larizza D, Livieri C, Cammareri V, Martini A, Plebani A, Zanaboni D, Severi F. Autoimmunity in children with diabetes mellitus and in their relatives. Eur J Pediatr 1986; 145: 182-184.
21. Lorini R, Vanelli M, the Prediabetes Study Group of the Italian Society for Pediatric Endocrinology and Dioabetology (SIEDP). Normal values of first-phase insulin response to intravenous glucose in healthy Italian children and adolescents. J Pediatr Endocrinol Metab 1996; 9: 163-167.
22. Lorini R, Orecchia G, Martinetti M, Dugoujon JM, Cuccia M. Autoimmunity in vitiligo: relationship with HLA, Gm and Km polymorphisms. Autoimmunity 1992; 11: 255-260.
23. Olerup O, Zetterquist H. HLA-DR typing by PCR amplifications with sequence-specific primers (PCR-SSP) in 2 hours: an alteration to serological DR typing in clinical practice including donor recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-235.
24. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes 1994; 43: 613-621.
25. Ohno Y, Aoki N, Nishimura A. In vitro production of interleukin-1, interleukin-6 and tumor necrosis factor-α in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1993; 77: 1072-1077.
26. Eizirik DL, Sandler S, Welsh N, Bendtzen K, Hellerstrom C. Nicotinamide decreases nitric oxide production and partially protects human pancreatic islet against the suppressive effects of combinations of cytokines. Autoimmunity 1994; 19: 193-198.
27. Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J. Human tumor necrosis factor potentiates human interleukin-1-mediated rat pancreatic β-cell cytotoxicity. J Immunol 1987; 139: 4077-4082.
28. Mehta V, Hao W, Brooks-Worrell BM, Palmer JP. The functional state of the beta cell modulates IL-1 and TNF-induced cytotoxicity. Lymphokine-Cytokine Res 1993; 12: 255-259.
29. Bendtzen K, Morling N, Fomsgaard A, Svenson M, Jakobsen B, Odum N, Svejgaard A. Association between HLA-DR-2 and production of tumor necrosis factor α and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol 1988; 28: 599-606.
30. Chofflon M, Juillard C, Juillard P, Gauthier G, Gran GE. TNF-α as a possible predictor relapse in patients with multiple sclerosis. Eur Cytokine Netw 1992; 3: 523-531.
31. Moreland LW, Baumgartner SW, Schiff HM, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB, Blosch CM. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis receptor (p75)-Fc fusion protein. N Engl J Med 1997; 337: 141-147.
32. Cope AP, Liblau RS, Yang XD, Congia M, Laudanna C, Schreiber RD, Probert L, Kollias G, McDevitt HO. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med 1997; 185: 1573-1584.
33. Jacob CO, Sadakazu A Michie SA, McDevitt HO, Acha-Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-α and interleukin 1. Proc Natl Acad Sei USA 1990; 87: 968-972.
34. Satoh J, Seino H, Abo T, Tanaka S, Shintani S, Ohta S, Tamura K, Sawai T, Nobunaga T, Oteki T, et al. Recombinant human necrosis factor-a suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest 1989; 84: 1345-1348.
35. Setoguchi J, Hashiramoto K, Nakarro K, Kitagawa Y, Nakamura T, Kondo M, Uno K. Prediction of insulin-dependent diabetes mellitus in non-obese diabetic mice by endogenous tumor necrosis factor alpha level. Diabete Res 1992; 19: 63-67.
36. Hussain MJ, Peakman M, Gallati H, Lo SSS, Hawa M, Viberti GC, Watkins PJ, Leslie RDG. Elevated serum levels of macrophage-derivated cytokines precede and accompany the onset of IDDM. Diabetologia 1996; 39: 60-69.
37. Hussain MJ, Maher J, Warnock T, Vats A, Peakman M, Vergani D. Cytokine overproduction in healthy first degree relatives of patients with IDDM. Diabetologia 1998; 41: 343-349.
38. Badenhoop K, Schwarz G, Trowsdale J, Lewis V, Usadel KH, Gale EAM, Bottazzo GF. TNF-α gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1989; 32: 445-448.
39. Inoko H, Trowsdale J. Linkage of TNF genes to HLA-B locus. Nucleic Acids Res 1987; 15: 8957-8962.